论文部分内容阅读
我院自1985年初引进广州产WFB—ⅡB增强型体外反搏装置应用于临床一年,为进一步了解和总结体外反搏对冠心病、心绞痛的疗效,现将资料完整的22例作分析如下: 病例选择及方法:临床已确诊的冠心病,有典型心绞痛发作史(包括劳累性或自发性心绞痛),治疗前心电图有心肌缺血性改变或休息时心电图正常运动后出现ST—T改变,无心律失常,血压稳定者作体外反搏治疗,反搏每次一小时/日,12次为一疗程,反搏前后做心电图对照,部分病例作心功能对照,治疗中停用强扩冠药物,有典型心绞痛症状而无心电图改变或经运动试验为阴性者均不在本文分析。
Our hospital since the introduction of Guangzhou in early 1985 WFB-ⅡB enhanced EECP device applied to clinical one year, in order to further understand and summarize the efficacy of EECP on coronary heart disease, angina pectoris, the data now complete analysis of 22 cases are as follows: Case selection and methods: Clinical diagnosis of coronary heart disease, history of typical angina pectoris (including exertion or spontaneous angina pectoris), pre-treatment electrocardiogram myocardial ischemia or resting ST-T changes after exercise, normal ECG Cardiac arrhythmia, stable blood pressure for external counterpulsation treatment, counterpulsation every hour / day, 12 times for a course of treatment, before and after counterpulsation to do ECG control, some cases for cardiac function control, disable the drug in treatment of coronary heart disease, None of the patients with typical angina symptoms who have ECG changes or those who are negative by exercise tests are not analyzed here.